293 filings
Page 4 of 15
8-K
gc9gsc3e53l49a3lhnyu
11 Oct 11
Maxygen Announces Final Rejection of All Claims of Amgen ‘804 Patent in Inter Partes Reexamination Proceeding
12:00am
UPLOAD
ze8qv9h
5 Oct 11
Letter from SEC
12:00am
CORRESP
ec9v30aj680ye93l
23 Sep 11
Correspondence with SEC
12:00am
UPLOAD
z61k8 em53noog
15 Sep 11
Letter from SEC
12:00am
CORRESP
l30oekl2pf5g jep
24 Aug 11
Correspondence with SEC
12:00am
UPLOAD
kztsc
17 Aug 11
Letter from SEC
12:00am
8-K
d5v9ii
8 Aug 11
Maxygen Reports Second Quarter 2011 Financial Results
12:00am
8-K
9h0qw b5zlymf9
31 May 11
Maxygen Announces $10 Million Stock Repurchase Program
12:00am
8-K
ab1 x0xfgcv
20 May 11
Entry into a Material Definitive Agreement
12:00am
8-K
64rhh 314y
5 May 11
Maxygen Reports First Quarter 2011 Financial Results
12:00am
ARS
15sq5oc
14 Apr 11
Annual report to shareholders
12:00am
DEFA14A
3cft1
13 Apr 11
Additional proxy soliciting materials
12:00am
8-K
ip6wgc9s3acyvlfbgom
17 Mar 11
Other Events
12:00am
8-K
xbo b4wqnsx39s6usc7
8 Mar 11
Maxygen Reports Fourth Quarter and Year End 2010 Financial Results
12:00am
8-K
oq4a4an7q2we73
31 Jan 11
Maxygen Announces Initiation of Phase I Clinical Trial
12:00am
8-K
n08kl0jh
16 Dec 10
Other Events
12:00am